Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moessner

Showing results (321-330 of 361) with videos related to

Pageof 37
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 17, 2009
Serotonin depletion hampers survival and proliferation in neurospheres derived from adult neural stem cellsJens Benninghoff, Angela Gritti, Matteo Rizzi, et al.
The International Journal of Eating Disorders|November 19, 2016
Predictors of dropout in face-to-face and internet-based cognitive-behavioral therapy for bulimia nervosa in a randomized controlled trialHunna J Watson, Michele D Levine, Stephanie C Zerwas, et al.
Mabs|March 18, 2016
XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancerJuergen M Schanzer, Katharina Wartha, Ekkehard Moessner, et al.
Psychotherapy and Psychosomatics|November 25, 2016
CBT4BN: A Randomized Controlled Trial of Online Chat and Face-to-Face Group Therapy for Bulimia NervosaStephanie C Zerwas, Hunna J Watson, Sara M Hofmeier, et al.
The Journal of Clinical Psychiatry|December 12, 2017
Cost-Effectiveness of Internet-Based Cognitive-Behavioral Treatment for Bulimia Nervosa: Results of a Randomized Controlled TrialHunna J Watson, Nicole McLagan, Stephanie C Zerwas, et al.
Plos One|August 31, 2013
Characterization of SLITRK1 variation in obsessive-compulsive disorderUzoezi Ozomaro, Guiqing Cai, Yuji Kajiwara, et al.
Journal of Autoimmunity|November 18, 2018
A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune diseaseLaurence B Peterson, Charles J M Bell, Sarah K Howlett, et al.
Journal of Autoimmunity|December 3, 2014
Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cellsCharles J M Bell, Yongliang Sun, Urszula M Nowak, et al.
Nature Materials|April 5, 2016
Proximate Kitaev quantum spin liquid behaviour in a honeycomb magnetA Banerjee, C A Bridges, J-Q Yan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 25, 2025
Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphomaZeno Riester, Marlena Surowka, Nicole Seifert, et al.
Pageof 37

Showing results (321-330 of 361) with videos related to

Sort By:
Pageof 37
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 17, 2009
Serotonin depletion hampers survival and proliferation in neurospheres derived from adult neural stem cellsJens Benninghoff, Angela Gritti, Matteo Rizzi, et al.
The International Journal of Eating Disorders|November 19, 2016
Predictors of dropout in face-to-face and internet-based cognitive-behavioral therapy for bulimia nervosa in a randomized controlled trialHunna J Watson, Michele D Levine, Stephanie C Zerwas, et al.
Mabs|March 18, 2016
XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancerJuergen M Schanzer, Katharina Wartha, Ekkehard Moessner, et al.
Psychotherapy and Psychosomatics|November 25, 2016
CBT4BN: A Randomized Controlled Trial of Online Chat and Face-to-Face Group Therapy for Bulimia NervosaStephanie C Zerwas, Hunna J Watson, Sara M Hofmeier, et al.
The Journal of Clinical Psychiatry|December 12, 2017
Cost-Effectiveness of Internet-Based Cognitive-Behavioral Treatment for Bulimia Nervosa: Results of a Randomized Controlled TrialHunna J Watson, Nicole McLagan, Stephanie C Zerwas, et al.
Plos One|August 31, 2013
Characterization of SLITRK1 variation in obsessive-compulsive disorderUzoezi Ozomaro, Guiqing Cai, Yuji Kajiwara, et al.
Journal of Autoimmunity|November 18, 2018
A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune diseaseLaurence B Peterson, Charles J M Bell, Sarah K Howlett, et al.
Journal of Autoimmunity|December 3, 2014
Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cellsCharles J M Bell, Yongliang Sun, Urszula M Nowak, et al.
Nature Materials|April 5, 2016
Proximate Kitaev quantum spin liquid behaviour in a honeycomb magnetA Banerjee, C A Bridges, J-Q Yan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 25, 2025
Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphomaZeno Riester, Marlena Surowka, Nicole Seifert, et al.
Pageof 37